The Effect Of Virtual Reality Glasses On Vital Signs And State Anxiety Level In Cancer Patients

Cancer Patients Clinical Trial

Official title:

The Effect Of Virtual Reality Glasses On Vital Signs And State Anxiety Level In Cancer Patients Receiving Chemotherapy For The First Time- Randomized Control Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05884047
• Other study ID #: Ankara Yilidirim Beyazit Un.
• Status: Completed
• Phase: N/A
• Start date: January 27, 2020
• Est. completion date: June 1, 2020

Study information

• Verified date: May 2023
• Source: Ankara Yildirim Beyazit University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study was conducted as a non-randomized control group experimental study to determine the effect of virtual reality glasses on vital signs and state anxiety levels.

Description:

Purpose This study was conducted as a non-randomized control group experimental study to determine the effect of virtual reality glasses on vital signs and state anxiety levels in cancer patients receiving chemotherapy for the first time.

Methods and Sample The population of the study was composed of adult patients admitted to an oncology hospital in Ankara province with a diagnosis of stage I-II-III cancer to undergo chemotherapy treatment for the first time. The sample of the study consisted of 30 patients who were assigned to the intervention and control groups by the stratified sampling method (considering such characteristics as age, gender, marital status). The patient identification form, Spielberger state anxiety scale, patient opinion form, vital signs follow-up form, and virtual reality glasses were used to collect the data.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: June 1, 2020
• Est. primary completion date: April 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Diagnosed with stage 1,2,3 cancer

• Receive radiotherapy and chemotherapy for the first time

• Volunteer patients who agreed to participate

Exclusion Criteria:

-Patients outside the inclusion criteria

Related Conditions & MeSH terms

• Cancer Patients

Intervention

Device:
• Virtual Glasses
In the research, Samsung Gear VR SM-R323 brand and model SG glasses provided by the researcher were used. Patients were offered four different options to watch as "Forest of Serenity", "Calm Place", "Happy Place", "Gala 360 Travel & Relax". Forest of Serenity is a nature video consisting of bird sounds, colorful trees and flowers, and a clear lake where fish can be seen swimming in it. Calm Place is a relaxing video where cycles are shown 24 hours a day, where a person finds himself by the lake in the forest in snowy, rainy sunny weather. In Happy Place, one finds himself in a virtual camp environment where natural events such as dynamically changing weather, day-night cycles, and falling stars are experienced. Gala 360 Travel & Relax is a Paris-Notre Dame museum tour video.

Locations

Country	Name	City	State
Turkey	Bahar Inkaya	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Bahar INKAYA

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Vital signs- Blood pressure	Systolic blood pressure values	first measurement just before the start of the chemotherapy infusion
Primary	Vital signs-pulse	Pulse values	first measurement just before the start of the chemotherapy infusion
Primary	Vital signs- Blood pressure	Systolic blood pressure values	the last measurement just after the end of the chemotherapy infusion
Primary	Vital signs-pulse	Pulse values	the last measurement just after the end of the chemotherapy infusion